Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results?

GeneDx Holdings Corp. (WGS) is slated to report its first-quarter 2025 results on April 30, before the market opens.The renowned genetic testing company reported adjusted earnings of 70 cents per share in the last reported quarter, topping the Zacks Consensus Estimate by a staggering 250%. GeneDx surpassed estimates in each of the trailing four quarters, the average surprise being 120.05%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)WGS’ Q1 EstimatesThe Zacks Consensus Estimate ...